ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,207Medicare Part D Prescriptions Filled, Including Refills

Rank: 212 out of 890

$575K Total Retail Price of All Prescriptions

Rank: 204 out of 890

218 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 218 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

26% of this provider’s 218 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 9,631 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
WARFARIN SODIUM 758 740 1 24
DONEPEZIL HCL 340 340 2 30
FUROSEMIDE 313 313 3 7
NAMENDA 285 283 4 36
POTASSIUM CHLORIDE 264 248 5 11
METOPROLOL TARTRATE 257 257 6 15
OMEPRAZOLE 235 210 7 8
LANTUS 230 203 8 50
LISINOPRIL 200 193 9 4
CEFTRIAXONE 186 184 10 239
LEVOTHYROXINE SODIUM 172 156 11 2
HYDROCODONE-ACETAMINOPHEN 170 169 S3 12 3
LACTULOSE 168 130 13 112
NEXIUM 167 167 14 14
ZOLPIDEM TARTRATE 164 151 15 19
AMLODIPINE BESYLATE 163 162 16 1
MEGESTROL ACETATE 126 122 R 17 92
CYMBALTA 124 101 18 45
AZITHROMYCIN 108 105 19 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 94 20 76
RISPERIDONE 99 99 21 78
CITALOPRAM HBR 97 89 22 20
QUETIAPINE FUMARATE 93 83 23 73
RANITIDINE HCL 92 92 24 49
SERTRALINE HCL 91 91 25 26
LIDOCAINE HCL 88 87 26 301
SIMVASTATIN 87 85 27 5
CLOPIDOGREL 87 87 27 28
METOPROLOL SUCCINATE 80 67 29 17
MIRTAZAPINE 79 72 30 82
AGGRENOX 76 76 31 219
ESCITALOPRAM OXALATE 70 70 32 51
OXYBUTYNIN CHLORIDE 68 61 33 139
GABAPENTIN 68 64 33 12
ALENDRONATE SODIUM 67 67 35 38
FINASTERIDE 66 66 36 108
BETHANECHOL CHLORIDE 65 52 37 362
PANTOPRAZOLE SODIUM 63 62 38 34
PRAVASTATIN SODIUM 62 59 39 10
NOVOLOG 58 53 40 178
DIVALPROEX SODIUM 58 58 40 126
NYSTATIN 58 50 40 173
MUPIROCIN 58 54 40 121
SEROQUEL 55 53 44 167
OLANZAPINE 54 52 45 145
OXYCODONE-ACETAMINOPHEN 54 50 S2 45 250
HYDROCHLOROTHIAZIDE 54 54 45 9
TAMSULOSIN HCL 50 50 48 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.